Schalnus R, Ohrloff C, Jungmann E, Maass K, Rinke S, Wagner A
Zentrum der Augenheilkunde, Johann-Wolfgang-Goethe Universität, Frankfurt am Main, Germany.
Ger J Ophthalmol. 1993 Aug;2(4-5):202-6.
For the evaluation of a possible malfunction of the blood-retinal barrier (BRB) and the blood-aqueous barrier (BAB) in type I diabetes without manifest angiopathy after i.v. injection of sodium fluorescein, the permeability of the BRB (P) and the permeability coefficient of the BAB [P(a)] were simultaneously determined by fluorophotometry in 34 eyes of 34 type-I diabetics [hemoglobin (Hb)A1c = 6.6% +/- 0.9%] without retinopathy whose age ranged from 19 to 38 years (mean, 30.5 +/- 5 years); the diabetes duration was between 5 and 18 years. Fluorescein angiography was performed to exclude nonperfused areas. In all, 34 eyes of 34 healthy volunteers whose age ranged between 23 and 34 years (mean, 28.5 +/- 3.3 years) served as controls; in this group, fluorophotometry was performed twice to evaluate reproducibility. The mean BAB permeability coefficient in diabetics [P(a) = 5.3 +/- 1.8 x 10(-4)/min] was significantly increased (P = 0.00003) as compared with control values [P(a) = 3.7 +/- 0.7 x 10(-4)/min]; BRB permeability in diabetics (P = 3.2 +/- 1.4 x 10(-7) cm/s) was raised, with this elevation being of lower significance (P = 0.019; controls, P = 2.6 +/- 0.7 x 10(-7) cm/s). We found a decrease in BRB permeability depending on diabetes duration (r = -0.15; P = 0.007) that was not significant in the BAB (r = -0.1; P = 0.24). No correlation was found to exist between permeability and hemoglobin (Hb)A1c values either in the BAB or in the BRB. The reproducibility in controls was 9% in BRB determinations and 12% in BAB measurements.(ABSTRACT TRUNCATED AT 250 WORDS)
为评估静脉注射荧光素钠后无明显血管病变的I型糖尿病患者血视网膜屏障(BRB)和血房水屏障(BAB)可能存在的功能障碍,通过荧光光度法同时测定了34例年龄在19至38岁(平均30.5±5岁)、无视网膜病变的I型糖尿病患者(糖化血红蛋白[Hb]A1c = 6.6%±0.9%)34只眼中BRB的通透性(P)和BAB的通透系数[P(a)];糖尿病病程为5至18年。进行荧光素血管造影以排除无灌注区。34例年龄在23至34岁(平均28.5±3.3岁)的健康志愿者的34只眼作为对照;对该组进行两次荧光光度法测定以评估重复性。糖尿病患者的平均BAB通透系数[P(a)=5.3±1.8×10(-4)/min]与对照值[P(a)=3.7±0.7×10(-4)/min]相比显著升高(P = 0.00003);糖尿病患者的BRB通透性(P = 3.2±1.4×10(-7) cm/s)升高,但升高的显著性较低(P = 0.019;对照组,P = 2.6±0.7×10(-7) cm/s)。我们发现BRB通透性随糖尿病病程而降低(r = -0.15;P = 0.007),而在BAB中不显著(r = -0.1;P = 0.24)。在BAB或BRB中,通透性与糖化血红蛋白(Hb)A1c值之间均未发现相关性。对照组中BRB测定的重复性为9%,BAB测量的重复性为12%。(摘要截短于250字)